The effects of antiglaucoma and systemic medications on ocular blood flow.
about
Retinal peripapillary blood flow before and after topical brinzolamideOcular Inserts for Sustained Release of the Angiotensin-Converting Enzyme 2 Activator, Diminazene Aceturate, to Treat Glaucoma in RatsBasic technique and anatomically imposed limitations of confocal scanning laser Doppler flowmetry at the optic nerve head level.Effect of trabeculectomy on ocular blood flow.Twenty-four hour blood pressure pattern in patients with normal tension glaucoma in the habitual positionThe association of ocular blood flow with haemorheological parameters in primary open-angle and exfoliative glaucoma.Functional and morphological effects of laser-induced ocular hypertension in retinas of adult albino Swiss mice.Brimonidine is neuroprotective against glutamate-induced neurotoxicity, oxidative stress, and hypoxia in purified rat retinal ganglion cells.Neuroprotective effect of peroxiredoxin 6 against hypoxia-induced retinal ganglion cell damage.The discovery of the Flammer syndrome: a historical and personal perspectiveOptical coherence tomography angiography of optic disc perfusion in glaucomaEvaluation of hemodynamic parameters as predictors of glaucoma progressionShort-term effects of acupuncture on open-angle glaucoma in retrobulbar circulation: additional therapy to standard medicationColor Doppler imaging analysis of retrobulbar blood flow velocities in primary open-angle glaucomatous eyes: a meta-analysisTopical combinations to treat microvascular dysfunction of chronic postischemia painYC-1 targeting of hypoxia-inducible factor-1α reduces RGC-5 cell viability and inhibits cell proliferationcGMP-Phosphodiesterase Inhibition Prevents Hypoxia-Induced Cell Death Activation in Porcine Retinal ExplantsTherapeutic strategies for normal-tension glaucoma.Comparison of intraocular pressure fluctuations measured by goldmann applanation tonometer and pulsatile ocular blood flow analyserBrinzolamide.Comparison of intraocular pressure, blood pressure, ocular perfusion pressure and blood flow fluctuations during dorzolamide versus timolol add-on therapy in prostaglandin analogue treated glaucoma subjectsNeuroprotection in glaucoma: drug-based approaches.Hypoxia-ischemia and retinal ganglion cell damage.Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension.Fixed combinations of dorzolamide-timolol and brimonidine-timolol in the management of glaucoma.The role of blood pressure in glaucoma.Use of colour Doppler imaging in ocular blood flow research.IGF-1 protects retinal ganglion cells from hypoxia-induced apoptosis by activating the Erk-1/2 and Akt pathways.Effect of trabeculectomy on retrobulbar circulation and visual field progression in patients with primary open-angle glaucoma.Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.Assessment of Optic Nerve Head Pallor in Primary Open-Angle Glaucoma Patients and Healthy Subjects.Ophthalmic drugs as part of polypharmacy in nursing home residents with glaucoma.Investigation of blood flow regulation and oxygen saturation of the retinal vessels in primary open-angle glaucoma.Application of Traditional Medical Ideas to Geriatric Syndrome
P2860
Q28295228-4A51FBC3-E084-4221-86B8-74E6744E5963Q28546739-718B6484-C304-4F77-944F-11A7BC8927DCQ30898469-93F9EEEB-A532-465E-BA7E-23A2F5E45F1CQ33211107-895CE229-3651-4812-B46A-2D9A2DE74F43Q33425242-C35B46AA-3C69-47BF-94DD-FF4FA92529C2Q33514076-6F5B7B0C-501A-4E76-A3E9-1B0C5DF91329Q33518577-18746B6D-1D1B-4296-B335-FE2A7AF2E530Q33655845-B8EF05A9-B1AE-4769-81FB-C5AC91D8ADBBQ33711010-2EE26943-F01F-4DFD-8A06-784D17A0FA46Q33840735-80B045F9-7161-483D-AD1F-2999A373A3EFQ33849239-C6E6C02B-9047-4692-A6D0-FC1CEF0B1175Q33902190-F0D36428-2716-4AAB-867B-7AA4835F1C3FQ34706537-960C729A-AECE-4226-B3CD-E5EACDAE6C5EQ34722647-B1B2F551-D501-436A-81C9-CE8AF2579A3BQ35126155-009E054E-7906-4631-B4C2-5C516085C28BQ36051597-AB66B024-2485-4842-9153-9576897D6928Q36197680-FAE0550D-001A-4818-8375-8558097840DCQ36312582-44353E13-1DB6-475D-B16F-35E74C7882D0Q36735289-1A44FA22-5BAA-4763-882C-671916641D7AQ37099034-7313662C-069A-4303-B2BD-C9D6107805B1Q37148706-88BF5055-D4D3-49CE-B48C-62D588C8EA58Q37180770-AED32B4B-0DA1-4672-AC03-90387F3E5FCFQ37236104-583D5BAA-36E9-4677-9B3C-FBBA34CE0E27Q37577462-FEF27B1A-65C1-4625-B3DB-3329E072E72CQ37716010-72D22D2C-47CB-4EF9-AB57-3FCFAB777EA3Q37831387-616350BF-DE71-4C1C-8F00-4013B393307AQ37944436-2BDF3C9F-B39A-4464-8982-DB6FB7BC88B6Q39613662-EF5819C0-91DC-4EC6-BCDD-E044259A0835Q42102905-6B5EF911-97F0-4167-AF16-87E65BC761A4Q46684073-F2FA32DB-7013-42D8-9EBA-B5FD2399581FQ48358031-3E6D6DB7-DA30-438D-810C-8EEFEBBBFD4CQ52885965-5C4BEE95-50B7-421F-A319-79E7CF0B36CEQ53056761-86D9CF5B-3703-4293-B945-620787859787Q59049881-F1A318A3-67AC-44C9-8B23-B6EBAB864EFA
P2860
The effects of antiglaucoma and systemic medications on ocular blood flow.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
The effects of antiglaucoma and systemic medications on ocular blood flow.
@ast
The effects of antiglaucoma and systemic medications on ocular blood flow.
@en
type
label
The effects of antiglaucoma and systemic medications on ocular blood flow.
@ast
The effects of antiglaucoma and systemic medications on ocular blood flow.
@en
prefLabel
The effects of antiglaucoma and systemic medications on ocular blood flow.
@ast
The effects of antiglaucoma and systemic medications on ocular blood flow.
@en
P2093
P1476
The effects of antiglaucoma and systemic medications on ocular blood flow.
@en
P2093
Alon Harris
Anders Heijl
Einar Stefánsson
Gunter K Krieglstein
Jean-Paul Renard
Josef Flammer
Luis Metzner Serra
Nicola Orzalesi
Vital P Costa
P304
P356
10.1016/S1350-9462(03)00064-8
P577
2003-11-01T00:00:00Z